First Drug for Smallpox Treatment Approved by FDA

The first drug with an indication for treatment of smallpox has been approved by the US Food and Drug Administration (FDA) and will be available for now only through the US government's Strategic National Stockpile (SNS).

The US Food and Drug Administration (FDA) has approved the first drug with an indication for treatment of smallpox.

Smallpox, a contagious and sometimes fatal infectious disease, was declared eradicated in 1980, by the World Health Organization. However, there have been longstanding concerns that smallpox could be used as a bioweapon.

Revelation Of How Poxviruses Such as Smallpox Evolve Rapidly Despite Low Mutation Rates: Researchers
Poxviruses are a group of DNA-containing viruses that includes smallpox. They are responsible for a wide range of diseases in humans and animals.

‘TPOXX (tecovirimat) is the FDA approved drug for smallpox treatment and will be available for now only through the US government's Strategic National Stockpile (SNS).’

TPOXX (tecovirimat) is a small-molecule antiviral treatment for smallpox, the first therapy specifically approved for this indication.

"To address the risk of bioterrorism, Congress has taken steps to enable the development and approval of countermeasures to thwart pathogens that could be employed as weapons. Today's approval provides an important milestone in these efforts. This new treatment affords us an additional option should smallpox ever be used as a bioweapon," Scott Gottlieb, FDA Commissioner, said in a statement.

The approval "reflects the FDA's commitment to ensuring that the US is prepared for any public health emergency with timely, safe and effective medical products", he added.

Much More Than Smallpox in the 'Forgotten Freezer'
An enquiry into the discovery of six vials of forgotten smallpox at a US government lab has revealed many more boxes containing infectious biological agents, US regulators said Wednesday.

TPOXX's effectiveness against smallpox was established by studies conducted in animals infected with viruses that are closely related to the virus that causes smallpox.

More animals treated with TPOXX lived compared to the animals treated with placebo.

Potential Use of Synthetic Horsepox Virus in Smallpox Vaccines and Cancer Therapy
Synthesis of pox viruses can be potentially useful in developing new and safer smallpox vaccines, as well as in the treatment of cancer.

Further, TPOXX's safety was also evaluated in 359 healthy human volunteers without a smallpox infection. The most frequently reported side effects were headache, nausea and abdominal pain.

TPOXX also received Orphan Drug designation, which provides incentives to assist and encourage the development of drugs for rare diseases and a Material Threat Medical Countermeasure Priority Review Voucher, which provides additional incentives for certain medical products intended to treat or prevent harm from specific chemical, biological, radiological and nuclear threats, the statement said.

New Light on the Historical Origin of Smallpox Vaccine
The smallpox vaccine can have potentially fatal side effects, so only the people who are at high risk of exposure get the vaccine.

The FDA granted approval of TPOXX to New York-based pharmaceutical company SIGA Technologies Inc and will be available initially only through the US government's Strategic National Stockpile (SNS).

Source-IANS